Skip to main content
SpringerLink
Log in

Independent assessment of source transit time for the BEBIG SagiNova® cobalt-60 high dose rate brachytherapy afterloader

  • Scientific Paper
  • Published:
Australasian Physical & Engineering Sciences in Medicine Aims and scope Submit manuscript

Abstract

Independent verification of transit time and the methodology employed in commercial high dose rate (HDR) afterloaders to compensate its effect is an important part of their commissioning and quality assurance. This study aimed to independently evaluate the Co-60 source transit time of the new BEBIG SagiNova® HDR afterloader unit by employing a dosimetric approach using a well-type ionization chamber. The source was placed at three dwell positions (DPs) to mimic a variety of clinical situations with different distances from the afterloader unit. The distances of the DPs to the afterloader were 129.37 cm, 124.50 cm and 118.57 cm. Plans were generated using the SagiPlan® treatment planning system to produce 3, 5, 10, 15, 20, 30, 40, 60 and 120 s dwell times (DTs). The residual transit times (following any possible system compensation) were assessed using the ESTRO-recommended approach of obtaining transit time compensation factors and another strategy established for teletherapy sources. The mean residual transit time depended on the distance between the afterloader and the DP, ranging from 0.43 to 1.10 s. The transit dose contribution was case-specific, ranging from 0.4% for a 60 s DT at the nearest DP to the afterloader up to 15.6% for a 3 s DT at the furthest DP from the unit. The results show that currently SagiNova® afterloader does not apply transit time compensation and suggest a 0.2–0.5 s compensation for each arrival and departure DP from/to the afterloader, depending on position in an 11 cm active length.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Giménez-Alventosa V, Vijande J, Ballester F, Perez-Calatayud J (2016) Transit dose comparisons for 60Co and 192Ir HDR sources. J Radiol Prot 36(4):858

    Article  Google Scholar 

  2. Wong TP, Fernando W, Johnston PN, Bubb IF (2001) Transit dose of an Ir-192 high dose rate brachytherapy stepping source. Phys Med Biol 46(2):323

    Article  CAS  Google Scholar 

  3. Palmer A, Mzenda B (2009) Performance assessment of the BEBIG MultiSource® high dose rate brachytherapy treatment unit. Phys Med Biol 54(24):7417

    Article  Google Scholar 

  4. Venselarr J, Perez-Calatayud J (2004) European guidelines for quality assurance in radiotherapy, ESTRO Booklet No 8. A practical guide to quality control of brachytherapy equipment. ESTRO, Belgium, pp 1–270

    Google Scholar 

  5. Fonseca G, Rubo R, Minamisawa R, Dos Santos G, Antunes P, Yoriyaz H (2013) Determination of transit dose profile for a 192Ir HDR source. Med Phys 40(5):51717

    Article  CAS  Google Scholar 

  6. Palmer A (2013) Impact of software changes: transit dose and source position accuracy of the Eckert & Ziegler BEBIG GmbH MultiSource® high dose rate (HDR) brachytherapy treatment unit. J Radiother Pract 12(1):80–87

    Article  Google Scholar 

  7. Fonseca GP, Viana RS, Podesta M, Rubo RA, Sales CP, Reniers B, Yoriyaz H, Verhaegen F (2015) HDR 192Ir source speed measurements using a high speed video camera. Med Phys 42(1):412–415

    Article  CAS  Google Scholar 

  8. Dempsey C, Smith R, Nyathi T, Ceylan A, Howard L, Patel V, Das R, Haworth A (2013) ACPSEM brachytherapy working group recommendations for quality assurance in brachytherapy. Australas Phys Eng Sci Med 36(4):387–396

    Article  Google Scholar 

  9. Fonseca G, Landry G, Reniers B, Hoffmann A, Rubo R, Antunes P, Yoriyaz H, Verhaegen F (2014) The contribution from transit dose for 192Ir HDR brachytherapy treatments. Phys Med Biol 59(7):1831.

    Article  CAS  Google Scholar 

  10. Sahoo N (2001) Measurement of transit time of a remote after-loading high dose rate brachytherapy source. Med Phys 28(8):1786–1790

    Article  CAS  Google Scholar 

  11. Jursinic PA (2014) Quality assurance measurements for high-dose-rate brachytherapy without film. J Appl Clin Med Phys 15(1):246–261

    Article  Google Scholar 

  12. Jeong J, Barker CA, Zaider M, Gil'ad NC (2016) Impact of source position on high-dose-rate skin surface applicator dosimetry. Brachytherapy 15(5):650–660

    Article  Google Scholar 

  13. Minamisawa R, Rubo R, Seraide R, Rocha J, Almeida A (2010) Direct measurement of instantaneous source speed for a HDR brachytherapy unit using an optical fiber based detector a. Med Phys 37(10):5407–5411

    Article  CAS  Google Scholar 

  14. Mukwada G, Neveri G, Alkhatib Z, Waterhouse DK, Ebert M (2016) Commissioning of a well type chamber for HDR and LDR brachytherapy applications: a review of methodology and outcomes. Australas Phys Eng Sci Med 39(1):167–175

    Article  Google Scholar 

  15. Wilkinson D (2006) High dose rate (HDR) brachytherapy quality assurance: a practical guide. Biomed Imaging Interv J 2(2):e34

    Article  CAS  Google Scholar 

  16. Podgorsak EB (2005) Radiation oncology physics. International Atomic Energy Agency, Vienna, pp 123–271

    Google Scholar 

  17. Kim Y, Modrick JM, Pennington EC, Kim Y (2016) Commissioning of a 3D image-based treatment planning system for high-dose-rate brachytherapy of cervical cancer. J Appl Clin Med Phys 17(2):405–426

    Article  Google Scholar 

  18. Supe SS, Bijina T, Varatharaj C, Shwetha B, Arunkumar T, Sathiyan S, Ganesh K, Ravikumar M (2009) Optimized dose distribution of Gammamed plus vaginal cylinders. J Med Dosim 34(1):20–25

    Article  Google Scholar 

  19. Oyekunle EO, Obed RI, Akinlade BI, Ntekim A (2015) Comparison of doses to the rectum derived from treatment planning system with in-vivo dose values in vaginal vault brachytherapy using cylinder applicators. J Contemp Brachytherapy 7(6):485

    Article  Google Scholar 

  20. Nag S (2004) High dose rate brachytherapy: its clinical applications and treatment guidelines. J Technol Cancer Res Treatment 3(3):269–287

    Article  Google Scholar 

Download references

Acknowledgements

The authors would like to thank Eckert & Ziegler BEBIG GmbH for helpful information, in particular, Antonius Spiller, Thomas Osche and Lars Flemmig for their valuable comments on the manuscript.

Funding

This study was funded by Shiraz University of Medical Sciences (Grant No. 97-07-75-18167).

Author information

Authors and Affiliations

  1. Ionizing and Non-Ionizing Radiation Protection Research Center, Paramedical School, Shiraz University of Medical Sciences, Shiraz, Iran

    Abolfazl Kanani & Mohammad Amin Mosleh-Shirazi

  2. Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran

    Abolfazl Kanani

  3. Physics Unit, Department of Radio-Oncology, Shiraz University of Medical Sciences, Shiraz, 71936-13311, Iran

    Sareh Karbasi & Mohammad Amin Mosleh-Shirazi

Authors
  1. Abolfazl Kanani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sareh Karbasi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mohammad Amin Mosleh-Shirazi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mohammad Amin Mosleh-Shirazi.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kanani, A., Karbasi, S. & Mosleh-Shirazi, M.A. Independent assessment of source transit time for the BEBIG SagiNova® cobalt-60 high dose rate brachytherapy afterloader. Australas Phys Eng Sci Med 42, 913–919 (2019). https://doi.org/10.1007/s13246-019-00788-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13246-019-00788-9

Keywords

Search

Navigation